Possible Mechanisms Underlying the Effects of Glucagon-Like Peptide-1 Receptor Agonist on Cocaine Use Disorder

What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?

Berridge, K. C., & Robinson, T. E. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00019-8 · Cited by 4,127 · see citing works

The Physiology of Glucagon-like Peptide 1

Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371 · see citing works

Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain.

Olds, J., & Milner, P. (1954) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0058775 · Cited by 3,176 · see citing works

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C. W., le Roux, C. W., Violante Ortiz, R., Jensen, C. B., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411892 · Cited by 2,724 · see citing works

Targeting the NLRP3 inflammasome in inflammatory diseases

Mangan, M. S. J., Olhava, E. J., Roush, W. R., Seidel, H. M., Glick, G. D., & Latz, E. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.97 · Cited by 1,885 · see citing works

Is there a common molecular pathway for addiction?

Nestler, E. J. (2005) · Nature Neuroscience · doi:10.1038/nn1578 · Cited by 1,388 · see citing works

Basic Neurochemistry???Molecular, Cellular, and Medical Aspects

Long, D. M. (2006) · Neurosurgery Quarterly · doi:10.1097/01.wnq.0000203279.82150.41 · Cited by 1,288 · see citing works

Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues

Tzschentke, T. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00060-4 · Cited by 1,254 · see citing works

Conditioned place preference: what does it add to our preclinical understanding of drug reward?

Bardo, M. T., & Bevins, R. A. (2000) · Psychopharmacology · doi:10.1007/s002130000569 · Cited by 1,233 · see citing works

How can drug addiction help us understand obesity?

Volkow, N. D., & Wise, R. A. (2005) · Nature Neuroscience · doi:10.1038/nn1452 · Cited by 1,089 · see citing works

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069 · see citing works

The dopamine motive system: implications for drug and food addiction

Volkow, N. D., Wise, R. A., & Baler, R. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.130 · Cited by 939 · see citing works

Minocycline: Far beyond an Antibiotic

Garrido‐Mesa, N., Zarzuelo, A., & Gálvez, J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12139 · Cited by 935 · see citing works

The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse?

Pierce, R. C., & Kumaresan, V. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.04.016 · Cited by 913 · see citing works

Memory and Addiction

Kelley, A. E. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.016 · Cited by 773 · see citing works

From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol

Wagner, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00367-0 · Cited by 739 · see citing works

Opioid use disorder

Strang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. L. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0137-5 · Cited by 639 · see citing works

International Union of Pharmacology. XXXIII. Mammalian γ-Aminobutyric AcidB Receptors: Structure and Function

Bowery, N. G., Bettler, B., Froestl, W., Gallagher, J. P., Marshall, F. H., Raiteri, M., Bonner, T. I., & Enna, S. J. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.247 · Cited by 601 · see citing works

GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism

Li, Y., Perry, T., Kindy, M. S., Harvey, B. K., Tweedie, D., Holloway, H. W., Powers, K., Shen, H., Egan, J. M., Sambamurti, K., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806720106 · Cited by 589 · see citing works

Glucagon-like peptide-1: a potent regulator of food intake in humans

Gutzwiller, J.-P., Göke, B., Drewe, J., Hildebrand, P., Ketterer, S., Handschin, D., Winterhalder, R., Conen, D., & Beglinger, C. (1999) · Gut · doi:10.1136/gut.44.1.81 · Cited by 571 · see citing works

TLR-signaling Networks

Brown, J. R., Wang, H., Hajishengallis, G., & Martin, M. (2010) · Journal of Dental Research · doi:10.1177/0022034510381264 · Cited by 534 · see citing works

Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2

Gutzwiller, J., Drewe, J., Göke, B., Schmidt, H., Rohrer, B., Lareida, J., & Beglinger, C. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.276.5.r1541 · Cited by 521 · see citing works

Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control

Lee, Y.-S., & Jun, H.-S. (2016) · Mediators of Inflammation · doi:10.1155/2016/3094642 · Cited by 503 · cited 1× · see citing works

Hindbrain Neurons as an Essential Hub in the Neuroanatomically Distributed Control of Energy Balance

Grill, H. J., & Hayes, M. R. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.015 · Cited by 483 · see citing works

Erratum: Targeting the NLRP3 inflammasome in inflammatory diseases

Mangan, M. S. J., Olhava, E. J., Roush, W. R., Seidel, H. M., Glick, G. D., & Latz, E. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.149 · Cited by 465 · see citing works

Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review

Deepmala, Slattery, J., Kumar, N., Delhey, L., Berk, M., Dean, O., Spielholz, C., & Frye, R. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.015 · Cited by 463 · see citing works

Modulation of inflammation in brain: A matter of fat

Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04371.x · Cited by 460 · see citing works

Structural Evidence for Functional Domains in the Rat Hippocampus

Risold, P., & Swanson, L. W. (1996) · Science · doi:10.1126/science.272.5267.1484 · Cited by 451 · see citing works

From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior

Williams, K. W., & Elmquist, J. K. (2012) · Nature Neuroscience · doi:10.1038/nn.3217 · Cited by 421 · see citing works

Discovery, characterization, and clinical development of the glucagon-like peptides

Drucker, D. J., Habener, J. F., & Holst, J. J. (2017) · Journal of Clinical Investigation · doi:10.1172/jci97233 · Cited by 418 · see citing works

A Range of Research-Based Pharmacotherapies for Addiction

O’Brien, C. P. (1997) · Science · doi:10.1126/science.278.5335.66 · Cited by 385 · see citing works

Common cellular and molecular mechanisms in obesity and drug addiction

Kenny, P. J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3105 · Cited by 382 · see citing works

Neural systems for behavioral activation and reward

Kalivas, P. W., & Nakamura, M. (1999) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(99)80031-2 · Cited by 335 · see citing works

GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease

Li, Y., Duffy, K. B., Ottinger, M. A., Ray, B., Bailey, J. A., Holloway, H. W., Tweedie, D., Perry, T., Mattson, M. P., Kapogiannis, D., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1314 · Cited by 319 · see citing works

Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?

Bassil, F., Fernagut, P., Bézard, E., & Meissner, W. G. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.02.005 · Cited by 313 · see citing works

Exenatide Exerts a Potent Antiinflammatory Effect

Chaudhuri, A., Ghanim, H., Vora, M., Sia, C. L., Korzeniewski, K., Dhindsa, S., Makdissi, A., & Dandona, P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1508 · Cited by 284 · see citing works

Opioid activation of Toll-Like receptor 4 contributes to drug reinforcement

Hutchinson, M., Northcutt, A., Hiranita, T., Wang, X.-H., Lewis, S. S., Thomas, J., van Steeg, K., Kopajtic, T., Loram, L., Sfregola, C., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0684-12.2012 · Cited by 279 · see citing works

The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide

Kanoski, S. E., Rupprecht, L. E., Fortin, S. M., De Jonghe, B. C., & Hayes, M. R. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.022 · Cited by 273 · see citing works

Hormones and the hippocampus

Lathe, R. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690205 · Cited by 272 · see citing works

Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse

Lacagnina, M. J., Rivera, P. D., & Bilbo, S. D. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.121 · Cited by 271 · see citing works

Cocaine‐induced neuroadaptations in glutamate transmission

Schmidt, H. D., & Pierce, R. C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05144.x · Cited by 254 · see citing works

The treatment of cocaine use disorder

Kampman, K. M. (2019) · Science Advances · doi:10.1126/sciadv.aax1532 · Cited by 250 · see citing works

Synaptic plasticity and drug addiction

Jones, S., & Bonci, A. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.08.011 · Cited by 245 · see citing works

Microglial TNF-α Suppresses Cocaine-Induced Plasticity and Behavioral Sensitization

Lewitus, G. M., Konefal, S., Greenhalgh, A. D., Pribiag, H., Augereau, K., & Stellwagen, D. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.030 · Cited by 244 · see citing works

Emerging role of Garcinol, the antioxidant chalcone from Garcinia indica Choisy and its synthetic analogs

Padhyé, S., Ahmad, A., Oswal, N., & Sarkar, F. H. (2009) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-2-38 · Cited by 241 · see citing works

Glutamate Receptors on Dopamine Neurons Control the Persistence of Cocaine Seeking

Engblom, D., Bilbao, A., Sanchis‐Segura, C., Dahan, L., Perreau‐Lenz, S., Balland, B., Parkitna, J. M. R., Luján, R., Halbout, B., Mameli, M., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.07.010 · Cited by 241 · see citing works

GABAB receptor agonists for the treatment of drug addiction: a review of recent findings

Cousins, M. S., Roberts, D. C. S., & de Wit, H. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00163-6 · Cited by 240 · see citing works

Intracellular Signals Mediating the Food Intake-Suppressive Effects of Hindbrain Glucagon-like Peptide-1 Receptor Activation

Hayes, M. R., Leichner, T. M., Zhao, S., Lee, G., Chowansky, A., Zimmer, D. J., Jonghe, B. C. D., Kanoski, S. E., Grill, H. J., & Bence, K. K. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.001 · Cited by 234 · see citing works

Glucagon‐like peptide‐1 receptor agonists in type 2 diabetes treatment: are they all the same?

Gentilella, R., Pechtner, V., Corcos, A., & Consoli, A. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3070 · Cited by 230 · see citing works

Repeated<i>N</i>-Acetylcysteine Administration Alters Plasticity-Dependent Effects of Cocaine

Madayag, A., Lobner, D., Kau, K. S., Mantsch, J. R., Abdulhameed, O., Hearing, M., Grier, M. D., & Baker, D. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2808-07.2007 · Cited by 225 · see citing works

DAT isn’t all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling

Northcutt, A. L., Hutchinson, M. R., Wang, X., Baratta, M. V., Hiranita, T., Cochran, T. A., Pomrenze, M. B., Galer, E. L., Kopajtic, T. A., Li, C. M., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.177 · Cited by 220 · see citing works

GLP-1 acts on habenular avoidance circuits to control nicotine intake

Tuesta, L. M., Chen, Z., Duncan, A., Fowler, C. D., Ishikawa, M., Lee, B. R., Liu, X.-A., Lu, Q., Cameron, M., Hayes, M. R., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4540 · Cited by 200 · see citing works

Endogenous Glucagon-like Peptide-1 Suppresses High-Fat Food Intake by Reducing Synaptic Drive onto Mesolimbic Dopamine Neurons

Wang, X.-F., Liu, J., Xia, J., Liu, J., Mirabella, V. R., & Pang, Z. P. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.062 · Cited by 180 · see citing works

A potential role for the hippocampus in energy intake and body weight regulation

Davidson, T. L., Kanoski, S. E., Schier, L. A., Clegg, D. J., & Benoit, S. C. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.10.008 · Cited by 178 · see citing works

Rational Development of Addiction Pharmacotherapies: Successes, Failures, and ProspectsPreprint

Pierce, R. C., O'Brien, C. P., Kenny, P. J., & Vanderschuren, L. J. M. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012880 · Cited by 178 · see citing works

The Glucagon-Like Peptide 1 Analogue, Exendin-4, Attenuates the Rewarding Properties of Psychostimulant Drugs in Mice

Egecioglu, E., Engel, J. A., & Jerlhag, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069010 · Cited by 176 · see citing works

Personalizing the Treatment of Substance Use Disorders

Volkow, N. D. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19121284 · Cited by 172 · see citing works

Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies

Kohno, M., Link, J., Dennis, L. E., McCready, H. D., Huckans, M. S., Hoffman, W. F., & Loftis, J. M. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.01.007 · Cited by 168 · see citing works

Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection.

Clark, K. H., Wiley, C. A., & Bradberry, C. W. (2013) · Neurotoxicity Research · doi:10.1007/s12640-012-9334-7 · Cited by 165 · see citing works

Toll-like receptor signaling and stages of addiction

Crews, F. T., Walter, T. J., Coleman, L. G., & Vetreno, R. P. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4560-6 · Cited by 159 · see citing works

The Glucagon-Like Peptide 1 Analogue Exendin-4 Attenuates the Nicotine-Induced Locomotor Stimulation, Accumbal Dopamine Release, Conditioned Place Preference as well as the Expression of Locomotor Sensitization in Mice

Egecioglu, E., Engel, J. A., & Jerlhag, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077284 · Cited by 158 · see citing works

Neuroprotective properties of GLP-1: theoretical and practical applications

Holst, J. J., Burcelin, R., & Nathanson, E. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.549466 · Cited by 152 · see citing works

Glucagon-Like Peptide-1 Receptor Activation in the Ventral Tegmental Area Decreases the Reinforcing Efficacy of Cocaine

Schmidt, H. D., Mietlicki-Baase, E. G., Ige, K. Y., Maurer, J. J., Reiner, D. J., Zimmer, D. J., Van Nest, D. S., Guercio, L. A., Wimmer, M. E., Olivos, D. R., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.362 · Cited by 148 · see citing works

The Role of Dopamine in Symptoms and Treatment of Apathy in Alzheimer's Disease

Mitchell, R., Herrmann, N., & Lanctôt, K. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00161.x · Cited by 141 · see citing works

A potential role for the gut microbiome in substance use disorders

Meckel, K. R., & Kiraly, D. D. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05232-0 · Cited by 141 · see citing works

The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice

Sørensen, G., Reddy, I. A., Weikop, P., Graham, D. L., Stanwood, G. D., Wortwein, G., Galli, A., & Fink-Jensen, A. (2015) · Physiology &amp; Behavior · doi:10.1016/j.physbeh.2015.06.013 · Cited by 140 · see citing works

The Immunobiology of Toll-Like Receptor 4 Agonists

Bohannon, J. K., Hernandez, A., Enkhbaatar, P., Adams, W. L., & Sherwood, E. R. (2013) · Shock · doi:10.1097/shk.0000000000000042 · Cited by 140 · see citing works

Role of Appetite-Regulating Peptides in the Pathophysiology of Addiction: Implications for Pharmacotherapy

Engel, J. A., & Jerlhag, E. (2014) · CNS Drugs · doi:10.1007/s40263-014-0178-y · Cited by 132 · see citing works

Can GLP-1 Be a Target for Reward System Related Disorders? A Qualitative Synthesis and Systematic Review Analysis of Studies on Palatable Food, Drugs of Abuse, and Alcohol

Eren, C. Y., Yigit, A., Dogruoz, E., & Eser, H. Y. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.614884 · Cited by 129 · see citing works

Role of oxidative metabolites of cocaine in toxicity and addiction: oxidative stress and electron transfer

Kovacic, P. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.06.028 · Cited by 128 · see citing works

Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats

Hernandez, N. S., Ige, K. Y., Mietlicki‐Baase, E. G., Molina-Castro, G. C., Turner, C. A., Hayes, M. R., & Schmidt, H. D. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0010-3 · Cited by 125 · see citing works

Glucagon-Like Peptide-1 Receptor Activation in the Nucleus Accumbens Core Suppresses Feeding by Increasing Glutamatergic AMPA/Kainate Signaling

Mietlicki‐Baase, E. G., Ortinski, P. I., Reiner, D. J., Sinon, C. G., McCutcheon, J. E., Pierce, R. C., Roitman, M. F., & Hayes, M. R. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0115-14.2014 · Cited by 122 · see citing works

Gender differences in cocaine dependent patients: a 6 month follow-up study

Weiss, R. D. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(96)01319-1 · Cited by 120 · see citing works

Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases

Gardoni, F., & Bellone, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00025 · Cited by 117 · see citing works

Cannabinoid CB1 Receptor Antagonists Attenuate Cocaine's Rewarding Effects: Experiments with Self-Administration and Brain-Stimulation Reward in Rats

Xi, Z., Spiller, K. J., Pak, A. C., Gilbert, J. G., Dillon, C., Li, X., Peng, X., & Gardner, E. L. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301552 · Cited by 115 · see citing works

GLP-1 analog attenuates cocaine reward

Graham, D. L., Erreger, K., Galli, A., & Stanwood, G. D. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.141 · Cited by 114 · see citing works

Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats

Hayes, M. R., Kanoski, S. E., Alhadeff, A. L., & Grill, H. J. (2011) · Obesity · doi:10.1038/oby.2011.50 · Cited by 110 · see citing works

CRF-Amplified Neuronal TLR4/MCP-1 Signaling Regulates Alcohol Self-Administration

June, H. L., Liu, J., Warnock, K. T., Bell, K., Balan, I. S., Bollino, D. R., Puché, A. C., & Aurelian, L. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.4 · Cited by 108 · see citing works

Effects of progesterone on the reinstatement of cocaine-seeking behavior in female rats.

Anker, J. J., Larson, E. B., Gliddon, L. A., & Carroll, M. E. (2007) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.15.5.472 · Cited by 107 · see citing works

Incretin Analogues that have been Developed to Treat Type 2 Diabetes Hold Promise as a Novel Treatment Strategy for Alzheimers Disease

Holscher, C. (2010) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488910791213130 · Cited by 102 · see citing works

Sex and estrogens alter the action of glucagon-like peptide-1 on reward

Richard, J. E., Anderberg, R. H., López-Ferreras, L., Olandersson, K., & Skibicka, K. P. (2016) · Biology of Sex Differences · doi:10.1186/s13293-016-0059-9 · Cited by 102 · see citing works

GLP-1 and Exendin-4 Transiently Enhance GABAA Receptor–Mediated Synaptic and Tonic Currents in Rat Hippocampal CA3 Pyramidal Neurons

Korol, S. V., Jin, Z., Babateen, O., & Birnir, B. (2015) · Diabetes · doi:10.2337/db14-0668 · Cited by 101 · see citing works

Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels

Reddy, I. A., Pino, J. A., Weikop, P., Osses, N., Sørensen, G., Bering, T., Valle, C., Bluett, R. J., Erreger, K., Wortwein, G., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.86 · Cited by 96 · see citing works

Exendin-4 decreases amphetamine-induced locomotor activity

Erreger, K., Davis, A. R., Poe, A. M., Greig, N. H., Stanwood, G. D., & Galli, A. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.03.014 · Cited by 94 · see citing works

Gut-brain axis and addictive disorders: A review with focus on alcohol and drugs of abuse

Jerlhag, E. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.005 · Cited by 92 · see citing works

Septal Glucagon-Like Peptide 1 Receptor Expression Determines Suppression of Cocaine-Induced Behavior

Harasta, A. E., Power, J., von Jonquières, G., Karl, T., Drucker, D. J., Housley, G. D., Schneider, M., & Klugmann, M. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.47 · Cited by 91 · see citing works

Central GLP-1 receptor activation modulates cocaine-evoked phasic dopamine signaling in the nucleus accumbens core

Fortin, S. M., & Roitman, M. F. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.03.019 · Cited by 88 · see citing works

Innate immune signaling in the ventral tegmental area contributes to drug-primed reinstatement of cocaine seeking

Brown, K. T., Levis, S. C., O’Neill, C. E., Northcutt, A. L., Fabisiak, T., Watkins, L. R., & Bachtell, R. K. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.08.012 · Cited by 88 · see citing works

Cocaine-induced oxidative stress precedes cell death in human neuronal progenitor cells

Poon, H. F., Abdullah, L. I., Mullan, M. A., MULLAN, M. J., & Crawford, F. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.06.012 · Cited by 87 · see citing works

Liraglutide, a glucagon-like peptide-1 receptor agonist, suppresses osteoclastogenesis through the inhibition of NF-κB and MAPK pathways via GLP-1R

Li, Z., Li, S., Wang, N., Xue, P., & Li, Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110523 · Cited by 78 · see citing works

Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder

Angarita, G. A., Matuskey, D., Pittman, B., Costeines, J. L., Potenza, M. N., Jastreboff, A. M., Schmidt, H. D., & Malison, R. T. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108614 · Cited by 75 · see citing works

Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid

Kozela, E., Juknat, A., & Vogel, Z. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081669 · Cited by 70 · see citing works

IL-10 normalizes aberrant amygdala GABA transmission and reverses anxiety-like behavior and dependence-induced escalation of alcohol intake

Patel, R. R., Wolfe, S. A., Bajo, M., Abeynaike, S. A., Pahng, A. R., Borgonetti, V., D’Ambrosio, S. R., Nikzad, R., Edwards, S., Paust, S., et al. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101952 · Cited by 70 · see citing works

GLP-1 receptor signaling in the laterodorsal tegmental nucleus attenuates cocaine seeking by activating GABAergic circuits that project to the VTA

Hernandez, N. S., Weir, V. R., Ragnini, K., Merkel, R., Zhang, Y., Mace, K. D., Rich, M. T., Pierce, R. C., & Schmidt, H. D. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00957-3 · Cited by 70 · see citing works

Coca: The History and Medical Significance of an Ancient Andean Tradition

Biondich, A. S., & Joslin, J. (2016) · Emergency Medicine International · doi:10.1155/2016/4048764 · Cited by 68 · see citing works

Toll-like receptor 4 deficiency alters nucleus accumbens synaptic physiology and drug reward behavior

Kashima, D. T., & Grueter, B. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705974114 · Cited by 66 · see citing works

Central GLP-1 receptors: Novel molecular targets for cocaine use disorder

Hernandez, N. S., & Schmidt, H. D. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.03.026 · Cited by 64 · see citing works

Ethanol Consumption in Mice Lacking CD14, TLR2, TLR4, or MyD88

Blednov, Y. A., Black, M., Chernis, J., Costa, A. D., Mayfield, J., & Harris, R. A. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13316 · Cited by 61 · see citing works

Early Prediction of Initiation of Abstinence from Cocaine:Use of a Craving Questionnaire

Weiss, R. D., Griffin, M. L., Hufford, C., Muenz, L. R., Najavits, L. M., Jansson, S. B., Kogan, J., & Thompson, H. J. (1997) · American Journal on Addictions · doi:10.3109/10550499709136989 · Cited by 59 · see citing works

Opportunities for the Development of Neuroimmune Therapies in Addiction

Ray, L. A., Roche, D. J. O., Heinzerling, K. G., & SHOPTAW, S. J. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801284-0.00012-9 · Cited by 58 · see citing works

Is there Epidemiological Evidence to Support the Idea that a Cocaine Dependence Syndrome Emerges Soon after Onset of Cocaine Use?

Reboussin, B. A., & Anthony, J. C. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301037 · Cited by 57 · see citing works

Endogenous DA-mediated feedback inhibition of DA neurons: Involvement of both D1- and D2-like receptors

Shi, W., Pun, C., Smith, P. L., & Bunney, B. S. (2000) · Synapse · doi:10.1002/(sici)1098-2396(200002)35:2 · Cited by 41 · see citing works

Prevention of suicide and reduction of self-harm among people with substance use disorder: a systematic review and meta-analysis of randomised controlled trials

Padmanathan, P., Hall, K., Moran, P., Jones, H. E., Gunnell, D., Carlisle, V., Lingford-Hughes, A., & Hickman, M. (2020) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2019.152135 · Cited by 41 · see citing works

The Gut Microbiome and Substance Use Disorder

Russell, J. T., Zhou, Y., Weinstock, G. M., & Bubier, J. A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.725500 · Cited by 40 · see citing works

Removal of microglial-specific MyD88 signaling alters dentate gyrus doublecortin and enhances opioid addiction-like behaviors

Rivera, P. D., Hanamsagar, R. M., Kan, M. J., Tran, P. K., Stewart, D. A., Jo, Y. C., Gunn, M. D., & Bilbo, S. D. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.11.010 · Cited by 39 · see citing works

Moving beyond energy homeostasis: New roles for glucagon-like peptide-1 in food and drug reward

Reddy, I. A., Stanwood, G. D., & Galli, A. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.10.003 · Cited by 36 · see citing works

Garcinol Blocks the Reconsolidation of Multiple Cocaine-Paired Cues after a Single Cocaine-Reactivation Session

Dunbar, A. B., & Taylor, J. R. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.27 · Cited by 35 · see citing works

Toll-like receptor 3 modulates the behavioral effects of cocaine in mice

Zhu, R., Bu, Q., Fu, D., Shao, X., Jiang, L., Guo, W., Chen, B., Liu, B., Hu, Z., Tian, J., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1130-8 · Cited by 35 · see citing works

The GLP-1 Receptor Agonist Exendin-4 and Diazepam Differentially Regulate GABAA Receptor-Mediated Tonic Currents in Rat Hippocampal CA3 Pyramidal Neurons

Korol, S. V., Jin, Z., & Birnir, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124765 · Cited by 26 · see citing works

The Naturally Occurring Compound Garcinia Indica Selectively Impairs the Reconsolidation of a Cocaine-Associated Memory

Monsey, M. S., Sanchez, H., & Taylor, J. R. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.117 · Cited by 24 · see citing works

Can cocaine-induced neuroinflammation explain maladaptive cocaine-associated memories?

Correia, C., Romieu, P., Olmstead, M. C., & Befort, K. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.01.001 · Cited by 24 · see citing works

Liraglutide modulates GABAergic signaling in rat hippocampal CA3 pyramidal neurons predominantly by presynaptic mechanism

Babateen, O., Korol, S. V., Jin, Z., Bhandage, A. K., Ahemaiti, A., & Birnir, B. (2017) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-017-0191-0 · Cited by 19 · see citing works

Deletion of Tlr3 reduces acute tolerance to alcohol and alcohol consumption in the intermittent access procedure in male mice

Blednov, Y. A., Costa, A. D., Mayfield, J., Harris, R. A., & Messing, R. O. (2020) · Addiction Biology · doi:10.1111/adb.12932 · Cited by 19 · see citing works

Glucagon-Like Peptide-1 Analog Exendin-4 Ameliorates Cocaine-Mediated Behavior by Inhibiting Toll-Like Receptor 4 Signaling in Mice

Zhu, C., Tao, H., Rong, S., Xiao, L., Li, X., Jiang, S., Guo, B., Wang, L., Ding, J., Gao, C., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.694476 · Cited by 13 · see citing works

Untitled work

(1971) · doi:10.1002/1097-4679(197110)27:4

Trial of Lixisenatide in Early Parkinson’s Disease

Meissner, W. G., Remy, P., Giordana, C., Maltête, D., Derkinderen, P., Houéto, J.-L., Anheim, M., Benatru, I., Boraud, T., Brefel-Courbon, C., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2312323 · Cited by 369 · see citing works

GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach

Arillotta, D., Floresta, G., Guirguis, A., Corkery, J. M., Catalani, V., Martinotti, G., Sensi, S. L., & Schifano, F. (2023) · Brain Sciences · doi:10.3390/brainsci13111503 · Cited by 104 · see citing works

Glucagon-like peptide 1 agonist and effects on reward behaviour: A systematic review

Badulescu, S., Tabassum, A., Le, G. H., Wong, S., Phan, L., Gill, H., Llach, C.-D., McIntyre, R. S., Rosenblat, J., & Mansur, R. (2024) · Physiology &amp; Behavior · doi:10.1016/j.physbeh.2024.114622 · Cited by 90 · see citing works

IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target

Bruns, N., Tressler, E. H., Vendruscolo, L. F., Leggio, L., & Farokhnia, M. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107312 · Cited by 89 · see citing works

12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study

Giorgi, R. D., Koychev, I. G., Adler, A., Cowen, P. J., Harmer, C. J., Harrison, P. J., & Taquet, M. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102726 · Cited by 82 · see citing works

Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach

Arillotta, D., Floresta, G., Pelletier, G. D. P., Guirguis, A., Corkery, J., Martinotti, G., & Schifano, F. (2024) · Brain Sciences · doi:10.3390/brainsci14060617 · Cited by 66 · see citing works

Anti-consumption agents: Tirzepatide and semaglutide for treating obesity-related diseases and addictions, and improving life expectancy

O'Keefe, J. H., Franco, W. G., & O'Keefe, E. L. (2025) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2024.12.010 · Cited by 42 · see citing works

GLP-1 Analogues in the Neurobiology of Addiction: Translational Insights and Therapeutic Perspectives

Marquez-Meneses, J. D., Olaya-Bonilla, S. A., Barrera-Carreño, S., Tibaduiza-Arévalo, L. C., Forero-Cárdenas, S., Carrillo-Vaca, L., Rojas-Rodríguez, L. C., Calderón‐Ospina, C., & Rodríguez, J. H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115338 · Cited by 46 · see citing works

Dopamine Pharmacodynamics: New Insights

Lauretani, F., Giallauria, F., Testa, C., Zinni, C., Lorenzi, B., Zucchini, I., Salvi, M., Napoli, R., & Maggio, M. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105293 · Cited by 34 · see citing works

The Clinical Application of GLP-1RAs and GLP-1/GIP Dual Receptor Agonists Based on Pharmacological Mechanisms: A Review

Liu, Z., Yu, S., Jin, X., Sheng, L., Rouzi, M. R. Y., Gao, J., Lü, J., & Lei, T. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s559919 · Cited by 29 · see citing works

Weight loss therapy and addiction: Increased risk after bariatric surgery but reduced risk with GLP-1 receptor agonists

Scheen, A. J. (2025) · Diabetes & Metabolism · doi:10.1016/j.diabet.2025.101612 · Cited by 15 · see citing works

A Qualitative Analysis of Patient Experiences Using Semaglutide 2.4 mg for Weight Loss

Plenn, E., Amin, D., Henry, J., Leavitt, G., Walker, J., & Soleymani, T. (2025) · Obesity Science &amp; Practice · doi:10.1002/osp4.70085 · Cited by 8 · see citing works

Weight‐reducing treatments are associated with an improvement in depression, functional health status, and quality of life: A meta‐analysis of randomized controlled trials

Silverii, G. A., Monami, M., Rotella, F., Luca, M. D., Viozzi, T., Barazzoni, R., Buscemi, S., Busetto, L., Sbraccia, P., & Mannucci, E. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70202 · Cited by 6 · see citing works

Tirzepatide versus semaglutide for the prevention of mild cognitive impairment, dementia, and Alzheimer's disease in type 2 diabetes: A real-world, retrospective cohort study

da Silva, A. M. P., Cardoso, L. J. C., Batista, S., Gonçalves, O. R., Paranhos, T., Teixeira, I. P. S., Guimarães, P. D., Franco, B. E., Cal, H., Salles, J. E. N., et al. (2026) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2026.109306 · Cited by 5 · see citing works

GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms

Rutigliani, G., Cross, T.-W., de Jong, E., Glover, E. S., Mendoza, I. D., Adisa, M., Tomoo, K., Zhou, X., & Mattes, R. D. (2026) · Obesity Reviews · doi:10.1111/obr.70148 · Cited by 5 · see citing works

Neuropsychiatric Effects of Tirzepatide: A Systematic Review and Meta-Analysis

Kamrul-Hasan, A. B. M., Borozan, S., Dutta, D., Nagendra, L., Shrestha, D., & Pappachan, J. M. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.12.017 · Cited by 5 · see citing works

Glucagon-like peptide-1 receptor agonists and mental health: a narrative review of emerging benefits and risks

Kim, J.-W. (2025) · Journal of Yeungnam Medical Science · doi:10.12701/jyms.2025.42.61 · Cited by 2 · see citing works

GLP1-receptor-agonisták a 2-es típusú diabetes vércukorcsökkentő kezelésében

Winkler, G. (2022) · Orvosi Hetilap · doi:10.1556/650.2022.32547 · Cited by 2 · see citing works

Estrogen regulation of the nucleus accumbens as a gateway to understanding menopause associated metabolic dysfunction

Rosenfeld, C. S., & Vieira‐Potter, V. J. (2025) · npj Women s Health · doi:10.1038/s44294-025-00071-1 · Cited by 1 · see citing works

Narrative review on glucagon-like peptide-1 receptor agonists and late-life depression: A new frontier in geriatric psychiatry?

Marano, G., Rossi, S., Lisci, F. M., Traversi, G., Mazza, O., Claro, A. E., Pola, R., Pitocco, D., Sani, G., Gaetani, E., et al. (2025) · Aging advances. · doi:10.4103/agingadv.agingadv-d-25-00027 · Cited by 1 · see citing works

A Shift from Diabetic Clinical Therapy to Aesthetic Use: The Ozempic Phenomenon

Sibarani, N. T., Simanjuntak, A. A., Simanjuntak, D. M. P., Tuba, S., Priyono, A., Sumaryono, B., & Sari, E. P. (2026) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2026.142019 · Cited by 1 · see citing works

New perspectives on the use of glucagon-like peptide 1 in diseases of the central nervous system

Łupina, M., & Listos, J. (2023) · Current Issues in Pharmacy and Medical Sciences · doi:10.2478/cipms-2023-0040

Pistes actuelles d’expérimentations pharmacologiques dans le traitement de la dépendance à la cocaïne

Marie, N., & Noble, F. (2024) · Psychotropes · doi:10.3917/psyt.294.0105

A current grasp of GLP-1 receptor agonists for addiction: emerging therapeutic potential

Moosa-Battey, R. (2025) · SA pharmaceutical journal. · doi:10.36303/sapj.2615

Interpretable machine learning for rare events: an inverse probability weighted application to understanding glucagon-like peptide-1 receptor agonists use and incident alcohol-related disorder

Gautam, R., Wang, H., Zhou, B., Neba, R. A., & Sambamoorthi, U. (2026) · Alcohol and Alcoholism · doi:10.1093/alcalc/agag045

GLP-1 agonists for smoking cessation and post-cessation weight management: A systematic review and meta-analysis of randomized trials

Heshmati, J., Mahmoodianfard, S., Raizman, E., Abraham, A., & Mir, H. R. (2026) · Tobacco Induced Diseases · doi:10.18332/tid/219815

Glucagon‐Like Peptide‐1 Receptor Agonists in Cocaine Use Disorder: Clinical Observations and Underlying Mechanisms

Eiden, C., Chautard, G., Batisse, A., Aquizerate, A., Luquiens, A., Donnadieu, H., Faillie, J., & Peyrière, H. (2026) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.70103

Central GLP-1 receptors: Novel molecular targets for cocaine use disorder

Hernandez, N. S., & Schmidt, H. D. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.03.026 · Cited by 64 · see citing works

The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice

Sørensen, G., Reddy, I. A., Weikop, P., Graham, D. L., Stanwood, G. D., Wortwein, G., Galli, A., & Fink-Jensen, A. (2015) · Physiology &amp; Behavior · doi:10.1016/j.physbeh.2015.06.013 · Cited by 140 · see citing works

Semaglutide suppresses cocaine taking, seeking, and cocaine-evoked dopamine levels in the nucleus accumbens

Aranäs, C., Caffrey, A., Edvardsson, C. E., Schmidt, H. D., & Jerlhag, E. (2025) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2025.07.001 · Cited by 21 · see citing works

The Role of The Central GLP-1 System in Cocaine-Seeking Behavior

Hernandez, N. S. (2019) · ScholarlyCommons (University of Pennsylvania)